Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | LLYEli Lilly and Company | NVSNovartis AG |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | Switzerland |
| Market cap | $1.3T | $308B |
| Price | $1432.29 | $163.26 |
| Last day | +1.44% | −0.26% |
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY analysis and Q-Scores →Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.